BK0456 Disperse Dyes
- 610.954
- +5.353+0.88%
Argus Research Initiates Coverage On Novo Nordisk With Buy Rating, Announces Price Target of $110
Argus Research analyst John Eade initiates coverage on Novo Nordisk (NYSE:NVO) with a Buy rating and announces Price Target of $110.
Argus Research Maintains Buy on Costco Wholesale, Raises Price Target to $650
Argus Research analyst Chris Graja maintains Costco Wholesale (NASDAQ:COST) with a Buy and raises the price target from $630 to $650.
Argus Research Reiterates Buy on Amazon.com, Maintains $165 Price Target
Argus Research analyst Jim Kelleher reiterates Amazon.com (NASDAQ:AMZN) with a Buy and maintains $165 price target.
Argus Research Reiterates Buy on Booking Holdings, Maintains $3677 Price Target
Argus Research analyst John Staszak reiterates Booking Holdings (NASDAQ:BKNG) with a Buy and maintains $3677 price target.
Argus Research Initiates Coverage On Choice Hotels Intl With Buy Rating, Announces Price Target of $145
Argus Research initiates coverage on Choice Hotels Intl (NYSE:CHH) with a Buy rating and announces Price Target of $145.
Argus Research Downgrades Splunk to Hold
Argus Research analyst Joseph Bonner downgrades Splunk (NASDAQ:SPLK) from Buy to Hold.
Silk Road Medical Downgraded at Argus on CMS Coverage Decision
Argus Research Maintains Buy on AutoZone, Raises Price Target to $2920
Argus Research analyst Taylor Conrad maintains AutoZone (NYSE:AZO) with a Buy and raises the price target from $2775 to $2920.
Argus Research Downgrades Silk Road Medical to Hold
Argus Research analyst Steve Silver downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold.
Argus Research Upgrades Regency Centers to Buy, Announces $70 Price Target
Argus Research analyst Angus Kelleher-Ferguson upgrades Regency Centers (NASDAQ:REG) from Hold to Buy and announces $70 price target.
MSCI Snags Buy Rating at Argus on Slew of Tailwinds
Argus Research Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $920
Argus Research analyst Jasper Hellweg maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target from $825 to $920.
Argus Research Initiates Coverage On Verisk Analytics With Buy Rating, Announces Price Target of $288
Argus Research initiates coverage on Verisk Analytics (NASDAQ:VRSK) with a Buy rating and announces Price Target of $288.
Argus Research Maintains Buy on Alcon, Raises Price Target to $95
Argus Research analyst John Staszak maintains Alcon (NYSE:ALC) with a Buy and raises the price target from $90 to $95.
Chewy Attracts a Bull Rating From Argus With Recurring Sales Growth and Higher Margins Anticipated
Argus Research Assumes Chewy at Buy, Announces Price Target of $30
Argus Research analyst Kristina Ruggeri assumes Chewy (NYSE:CHWY) with a Buy rating and announces Price Target of $30.
Argus Research Maintains Buy on MongoDB, Raises Price Target to $484
Argus Research analyst Joseph Bonner maintains MongoDB (NASDAQ:MDB) with a Buy and raises the price target from $435 to $484.
Argus Research Downgrades British American Tobacco to Hold
Argus Research analyst David Coleman downgrades British American Tobacco (NYSE:BTI) from Buy to Hold.
Argus Research Maintains Buy on Arthur J. Gallagher, Raises Price Target to $264
Argus Research analyst John Staszak maintains Arthur J. Gallagher (NYSE:AJG) with a Buy and raises the price target from $232 to $264.
Argus Research Maintains Buy on Gentherm, Lowers Price Target to $68
Argus Research analyst David Coleman maintains Gentherm (NASDAQ:THRM) with a Buy and lowers the price target from $80 to $68.